Milestone Approval of Invasive Brain-Computer I...

By João L. Carapinha

March 20, 2026

China's National Medical Products Administration (NMPA) has approved the world's first invasive brain-computer interface medical device for market entry. Develope...
Europe Life Sciences Competitiveness: Addressing Decline and Unlocking Potential
Revised MenACWY Vaccination Strategy for Adolescents in Germany
Advancements in Uncertainty-Aware Diagnostics with ConfiDx LLM
Surge in Obesity Intervention Costs in the Netherlands
FDA Confirms GLP-1 RA Safety Review: No Increased Suicidal Risk
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investmen...
FDA Updates Labeling on Febrile Seizure Risks in Influenza Vaccine for Children
Equity-Based Pricing: Enhancing Value in Primary Care through Socioeconomic C...
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Positive ARTISTRY-2 Trial Results for BIC LEN HIV Regimen
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare